Cannabichromenic Acid (CBC-a) Cannabinoid Research

Cannabichromenic Acid (CBC-a) Research Dashboard

Loading research dashboard…

Loading Primary Studies…

Loading Related Studies…

Overview - Cannabichromenic Acid (CBC-a)

Description of Cannabichromenic Acid (CBC-a)

Cannabichromenic acid (CBCA) was isolated, and its structure was defined by a team of Japanese researchers (Y. Shoyama et al., 1968). CBCA is the precursor to CBC.

Other Names:

Cannabichromenic Acid

Cannabichromenic acid, (+)-Cannabichromenic acid and other supplier-based synonyms.


IUPAC Name: 5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromene-6-carboxylic acid


Molecular Formula: C22H30O4


Source–PubChem

Cannabichromenic Acid (CBC-a) Properties and Effects

Only Members can view Properties and Effects information. See DEMO page.

Cannabichromenic Acid (CBC-a) Receptor Binding

Only Members can view Receptor Binding information. See DEMO page.

Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.